Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.

Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, Didolkar V, Vets E, Gottesdiener K, Wagner JA.

J Clin Pharmacol. 2009 Jan;49(1):80-7. doi: 10.1177/0091270008326718. Epub 2008 Nov 11.

PMID:
19004846
2.

Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.

Chen Q, Doss GA, Tung EC, Liu W, Tang YS, Braun MP, Didolkar V, Strauss JR, Wang RW, Stearns RA, Evans DC, Baillie TA, Tang W.

Drug Metab Dispos. 2006 Jan;34(1):145-51. Epub 2005 Oct 26.

PMID:
16251255
3.

Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.

Kumar S, Kwei GY, Poon GK, Iliff SA, Wang Y, Chen Q, Franklin RB, Didolkar V, Wang RW, Yamazaki M, Chiu SH, Lin JH, Pearson PG, Baillie TA.

J Pharmacol Exp Ther. 2003 Mar;304(3):1161-71.

PMID:
12604693
4.

Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery.

Poon GK, Kwei G, Wang R, Lyons K, Chen Q, Didolkar V, Hop CE.

Rapid Commun Mass Spectrom. 1999;13(19):1943-50.

PMID:
10487941
5.

Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway.

Ding VD, Moller DE, Feeney WP, Didolkar V, Nakhla AM, Rhodes L, Rosner W, Smith RG.

Endocrinology. 1998 Jan;139(1):213-8.

PMID:
9421417
6.

Cloning and analysis of the genes for polycyclic aromatic hydrocarbon degradation.

Zylstra GJ, Wang XP, Kim E, Didolkar VA.

Ann N Y Acad Sci. 1994 May 2;721:386-98.

PMID:
8010687

Supplemental Content

Loading ...
Support Center